Expression of CD45-Restricted Form B in (NZW × BXSB) F1 and MRL/Mp-1pr/1pr Mice

References

• Thomas M. L. The Leukocyte Common Antigen Family. Annu. Rev. Immunol. 1989; 7: 339–369
   PubMed Web of Science ®Google Scholar
• Saga Y., Tung J. S., Shen F. W., Boyse E. A. Sequences of Ly-5 cDNA: Isoform-related diversity of Ly-5 mRNA. Proc. Natl. Acad Sci. USA 1986; 83: 6940–6944
   PubMedGoogle Scholar
• Thomas M. L., Reynolds P. J., Chain A., Ben-Neriah Y., Trowbridge I. S. B-cell variant of mouse T200(Ly-5): Evidence for alternative mRNA splicing. Proc. Natl. Acad. Sci. USA 1987; 84: 5360–5363
   PubMedGoogle Scholar
• Streuli M., Hall L. R., Saga Y., Schlossman S. F., Saito H. Differential usage of three exons generates at least five different mRNAs encoding human leukocyte common antigens. J. Exp. Med 1987; 166: 1547–1565
   Google Scholar
• Barclay A. N., Jackson D. I., Willis A. C., Williams A. F. Lymphocyte specific heterogencity in the rat leucocyte common antigen (T200) is due to differences in polypeptide sequences near the NH2-terminus. EMBO. J. 1987; 6: 1259–1264
   PubMedGoogle Scholar
• Birkeland L. M., Johnson P., Trowbridge I. S., Pure E. Changes in CD45 isoforms expression accompany antigen-induced murine T-cell activation. Proc., Natl. Acad Sci. USA 1989; 86: 6734–6738
   PubMedGoogle Scholar
• Hathcock K. S., Hirano H., Murakami S., Hodes R. J. CD45 expression by B cells: Expression of different CD45 isoforms by subpopulations of activated B cells. J. Immunol. 1992; 49: 2286–2294
   Google Scholar
• Hang L. M., Izui S., Dixon F. J. (NZW × BXSB)F1 hybrid. A model of acute lupus and coronary vascular disease with myocardial infarction. J. Exp. Med. 1981; 154: 216–221
   PubMed Web of Science ®Google Scholar
• Oyaizu N., Yasumizu K., Inaba M., Nomura S., Yoshida H. S., Miyawaki S., et al. (NZW × BXSB)F1 mouse: A new animal model of idiopathic thrombocytopenic purpura. J. Exp. Med. 1988; 167: 2017–2022
   PubMed Web of Science ®Google Scholar
• Adachi Y., Inaba M., Inaba K., Than Soe, Kobayashi Y., Ikehara S. Analyses of thymic abnormalities in autoimmune-prone (NZW × BXSB)F1 Mice. Immunobiol 1993; 188: 340–354
   Google Scholar
• Hashimoto Y., Kawamura M., Ichikawa K., Suzuka T., Sumida T., Yoshida S., et al. Anticardiolipin antibodies in NZW × BXSB F1 mice: A Model of Antiphospholipid Syndrome. J. Immunol. 1992; 149: 1063–1068
   PubMed Web of Science ®Google Scholar
• Andrew B. S., Eisenberg R. A., Theofilopoulos A. N., Izui S., Wilson C. B., McConahey P. J., et al. Spontaneous murine lupus-like syndrome. J. Exp. Med. 1978; 148: 1198–1215
   PubMedGoogle Scholar
• Theofilopoulos A. N., Dixon F. J. Murine model of systemic lupus erythematosus. Adv. Immunol. 1985; 37: 269–390
   PubMed Web of Science ®Google Scholar
• Koike T., Sueichi M., Funaki M., Tomioka H., Yoshida S. Antiphospholipid antibodies and biological false positive serological test for syphilis in patients with systemic lupus erythematosus. Clin. Exp. Immunol. 1984; 56: 193
   PubMed Web of Science ®Google Scholar
• Ichikawa K., Shimada K., Nawata Y., Ishii T., Tomita T., Yoshida S., et al. Monoclonal hybridoma anticardiolipin antibodies from SLE mice. Clin. Exp. Immunol. 1988; 74: 110
   PubMedGoogle Scholar
• Hashimoto Y., Kawamura M., Ichikawa K., Suzuki T., Sumida T., Yoshida S., et al. Anticardiolipin antibodies in NZW × BXSB FI mice, a model of anticardiolipin syndrome. J. Immunol. 1992; 149: 1063
   PubMed Web of Science ®Google Scholar
• Nagata N., Yasumizu R., Onishi Y., Nakagawa T., Inaba M., Ikehara S. 1990. Auto-MHC class-II-reactive T cell line obtained from MRL/+ mice suffering from »1pr-GVHD« I. Characterization of Surface Phenotypes, Specificities and Functions in vitro. Immunobiol. 1990; 181: 367
   Google Scholar
• Singer P. A., Theofilopoulos A. N. T-cell receptor Vβ Repertoire expression in murine models of SLE. Immunol. Rev 1990; 18: 102–127
   Google Scholar
• Schleiffenbaum B., Spertini O., Tedder T. F. Soluble L-selectin is present in human plasma at high levels and retains functional activity. J. Cell. Biol. 1992; 119: 229–238
   PubMed Web of Science ®Google Scholar
• Paterson D. J., Jefferies W. A., Green J. R., Brandon M. R., Corthesy P., Puklavee M., Williams A. F. Antigens of activated rat T lymphocytes including a molecule of 50,000 m detected only on CD4 positive T blasts. Mol. Immunol. 1987; 24: 1281–1290
   PubMed Web of Science ®Google Scholar
• Hang L. E., Theofilopoulos A. N., Balderas R. S., Francis S. J., Dixon F. J. The effect of thymectomy on lupus-prone mice. J. Immunol 1984; 132: 1809–1813
   PubMed Web of Science ®Google Scholar
• Gershwin M. E., Ohsugi Y., Ahmed A., Castles J. J., Scibienski R., Ikeda R. M. Studies of congenitally immunologically mutant New Zealand mice. IV. Development of autoimmunity in congenitally athymic (nude) New Zealand black × white F1 hybrid mice. J. Immunol. 1980; 125: 1189–1195
   Google Scholar
• Wofsy D., Ledbetter J. A., Hendler P. L., Seaman W. E. Treatment of murine lupus with monoclonal anti-T cell antibody. J. Immunol. 1985; 134: 852–857
   PubMed Web of Science ®Google Scholar
• Wofsy D., Seaman W. E. Successful treatment of autoimmunity in NZB/NZW F1 mice with monoclonal antibody to L3T4. J. Exp. Med. 1985; 161: 378–391
   PubMed Web of Science ®Google Scholar
• Santoro T. J., Portanova J. P., Kotzin B. L. The contribution of L3T4 T cells to lymphoproliferation and autoantibody production in MRL-1pr/1pr mice. J. Exp. Med 1988; 167: 1713–1718
   PubMedGoogle Scholar
• Jabs D. J., Burek C. L., Qile Hu., Kuppers K. C., Lee B., Prendergast R. A. Anti-CD4 monoclonal antibody therapy suppresses autoimmune disease in MRL/Mp-1pr/lpr mice. Cell. Immunol. 1992; 141: 496–507
   PubMedGoogle Scholar
• Adachi Y., Inaba M., Amoh Y., Yoshifusa H., Nakamura Y., Suzuka H., et al. Effect of bone marrow transplantation on anti-phospholipid antibody syndrome in murine lupus mice. Immunobiol. 1995; 192: 218–230
   PubMed Web of Science ®Google Scholar
• Althan A., Theofilopoulos A. N., Weiner R., Katz D. H., Dixon F. J. Analysis of T cell function in autoimmune murine strains. Defects in production of and responsiveness to interleukin 2. J. Exp. Med 1981; 154: 791–808
   Google Scholar
• Kroemer G., Andreu J. L., Gonzalo J. A., Gutierrezramos J. C., Martinez A. C. Intcrlcukin-2. Autotolerance, and Autoimmunity. Adv. Immunol. 1991; 50: 147–231
   PubMed Web of Science ®Google Scholar
• Balderas K. S., Josimovie-Alasevie O., Diamanstein T., Dixon F. J., Theofilopoulos A. N. Elevated titers of cell-lice interlcukin 2 receptor in serum of lupus mice. J. Immunol 1987; 139: 1496–1500
   PubMedGoogle Scholar